✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹827 Cr.
P/E
21.37

Key Ratios

Market cap
Market cap
827 Cr
PE
PE
21.37
Prom Holding
Prom Holding
71.82 %
ROE (%)
ROE (%)
14.52
ROCE (%)
ROCE (%)
19.09
Div Yield (%)
Div Yield (%)
1.82
Sales
Sales
730 Cr
OPM (%)
OPM (%)
7.62 %
Debt to Equity
Debt to Equity
0.03

About

Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (API… Read more
Low
74
52W Range
High
121
  • Anuh Pharma
  • Wanbury
  • Sakar Healthcare
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

9 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

22 %
(as of Mar 22)
Chloramphenicol - Market Share
7 %
(as of Mar 22)
Corticosteroids - Market Share
18 %
(as of Mar 22)
Erythromycin - Market Share
2 %
(as of Mar 22)
Higher Macrolides(Azithromycin)
33 %
(as of Mar 22)
Pyrazinamide - Market Share
12.50 %
(as of Mar 22)
Sulfaxoxine

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Brand Wise Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Anuh Pharma Ltd. Business

    Anuh Pharma Ltd is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and also deals in bulk drugs, chemicals, and pharmaceutical formulations.

    Anuh Pharma major competitors are Wanbury, Sakar Healthcare, Ind-Swift Lab., Fredun Pharma, Bharat Parenterals, Kwality Pharma, Lincoln Pharma.
    Market Cap of Anuh Pharma is ₹827 Crs.
    While the median market cap of its peers are ₹836 Crs.

    Anuh Pharma seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material